Zhao Z - Search Results

1

Case report: Supratherapeutic tacrolimus concentrations with nirmatrelvir/ritonavir in a lung transplant patient: a case report using Rifampin for reversal.

Xiong Y, Wang X, Li S, Zhang Q, Guo L, Chen W, Zhao Z, Liu L. Xiong Y, et al. Among authors: zhao z. Front Pharmacol. 2023 Nov 10;14:1285078. doi: 10.3389/fphar.2023.1285078. eCollection 2023. Front Pharmacol. 2023. PMID: 38026995 Free PMC article.

2

Open-Label, Randomized, Single-Dose, 2-Period, 2-Sequence Crossover, Comparative Pharmacokinetic Study to Evaluate Bioequivalence of 2 Oral Formulations of Olanzapine Under Fasting and Fed Conditions.

Du P, Li P, Liu H, Zhao R, Zhao Z, Yu W, Zhou X, Liu L. Du P, et al. Among authors: zhao z, zhao r. Clin Pharmacol Drug Dev. 2020 Jul;9(5):621-628. doi: 10.1002/cpdd.743. Epub 2019 Oct 8. Clin Pharmacol Drug Dev. 2020. PMID: 31595704 Clinical Trial.

3

Impact of 'Chief-Pharmacist System' on drug expenditures and rational drug use.

Ma Z, Zhao Z, Sun S, Li Y, An Z, Yan Y, Liu L. Ma Z, et al. Among authors: zhao z. Int J Clin Pharm. 2020 Feb;42(1):167-173. doi: 10.1007/s11096-019-00954-9. Epub 2020 Jan 9. Int J Clin Pharm. 2020. PMID: 31919733

4

Determinants of gefitinib pharmacokinetics in healthy Chinese male subjects: A pharmacogenomic study of cytochrome p450 enzymes and transporters.

Wan Z, Guo L, Li P, Zhao Z, Xu B, Ren L, Yan Y, Liu H, Zhang Y, Liu L. Wan Z, et al. Among authors: zhao z. J Clin Pharm Ther. 2020 Oct;45(5):1159-1167. doi: 10.1111/jcpt.13168. Epub 2020 Jun 20. J Clin Pharm Ther. 2020. PMID: 32562509

5

Lenvatinib and osteonecrosis of the jaw: A pharmacovigilance study.

Lu W, Guo Q, Ma Z, Liu L, Zhao Z. Lu W, et al. Among authors: zhao z. Eur J Cancer. 2021 Jun;150:211-213. doi: 10.1016/j.ejca.2021.03.046. Epub 2021 May 3. Eur J Cancer. 2021. PMID: 33934057 No abstract available.

6

Risk of pneumonitis in cancer patients treated with PARP inhibitors: A meta-analysis of randomized controlled trials and a pharmacovigilance study of the FAERS database.

Ma Z, Sun X, Zhao Z, Lu W, Guo Q, Wang S, You J, Zhang Y, Liu L. Ma Z, et al. Among authors: zhao z. Gynecol Oncol. 2021 Aug;162(2):496-505. doi: 10.1016/j.ygyno.2021.05.012. Epub 2021 May 19. Gynecol Oncol. 2021. PMID: 34023129

7

Pericardial Toxicities Associated With Immune Checkpoint Inhibitors: A Pharmacovigilance Analysis of the FDA Adverse Event Reporting System (FAERS) Database.

Ma Z, Pei J, Sun X, Liu L, Lu W, Guo Q, Lyu J, Liu Y, Zhang Y, Zhao Z. Ma Z, et al. Among authors: zhao z. Front Pharmacol. 2021 Jul 2;12:663088. doi: 10.3389/fphar.2021.663088. eCollection 2021. Front Pharmacol. 2021. PMID: 34276364 Free PMC article.

8

Efficacy and safety of PARP inhibitors in patients with BRCA-mutated advanced breast cancer: A meta-analysis and systematic review.

Sun X, Wang X, Zhang J, Zhao Z, Feng X, Liu L, Ma Z. Sun X, et al. Among authors: zhao z. Breast. 2021 Dec;60:26-34. doi: 10.1016/j.breast.2021.08.009. Epub 2021 Aug 21. Breast. 2021. PMID: 34455227 Free PMC article.

9

Anti-angiogenic agent-associated adrenal insufficiency in immune checkpoint inhibitors-treated patients.

Guo Q, Lu W, Sun X, Zhao Z, Liu L. Guo Q, et al. Among authors: zhao z. Eur J Cancer. 2021 Nov;157:358-360. doi: 10.1016/j.ejca.2021.08.038. Epub 2021 Sep 23. Eur J Cancer. 2021. PMID: 34563990 No abstract available.

10

Study on the Relationship between Rivaroxaban and Factor Xa Activity in Blood Based on HPLC-MS/MS.

Liu H, Zhao Z, Wang Y, Liu L, Yang Y, An Z. Liu H, et al. Among authors: zhao z. Curr Drug Metab. 2021;22(14):1132-1138. doi: 10.2174/1389200222666211126093627. Curr Drug Metab. 2021. PMID: 34825867

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

32,104 results

Search Page

Filters